Current Assets
Allowance for Doubtful Accounts
Pfizer Allowance for Doubtful Accounts decreased by 0.5% to $425.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.5%, from $427.00M to $425.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts shows a downward trend with a -3.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase suggests rising credit risk or economic stress among the customer base.
Detailed definition
A contra-asset account that represents the estimated portion of accounts receivable that the company does not expect to...
Peer comparison
Standard across all utilities; levels are often influenced by regulatory mandates regarding service disconnection policies.
Metric ID:
allowance_for_doubtful_accountsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $500.00M | $494.00M | $492.00M | $492.00M | $461.00M | $474.00M | $449.00M | $465.00M | $471.00M | $465.00M | $470.00M | $479.00M | $468.00M | $465.00M | $438.00M | $427.00M | $439.00M | $434.00M | $427.00M | $425.00M |
| QoQ Change | — | -1.2% | -0.4% | +0.0% | -6.3% | +2.8% | -5.3% | +3.6% | +1.3% | -1.3% | +1.1% | +1.9% | -2.3% | -0.6% | -5.8% | -2.5% | +2.8% | -1.1% | -1.6% | -0.5% |
| YoY Change | — | — | — | — | -7.8% | -4.0% | -8.7% | -5.5% | +2.2% | -1.9% | +4.7% | +3.0% | -0.6% | +0.0% | -6.8% | -10.9% | -6.2% | -6.7% | -2.5% | -0.5% |
Range$425.00M – $500.00M
CAGR-3.4%
Avg YoY Growth-3.3%
Median YoY Growth-3.3%
Current Streak3 quarters decline
Allowance for Doubtful Accounts at Other Companies
Frequently Asked Questions
- What is Pfizer's allowance for doubtful accounts?
- Pfizer (PFE) reported allowance for doubtful accounts of $425.00M in Q1 2026.
- How has Pfizer's allowance for doubtful accounts changed year-over-year?
- Pfizer's allowance for doubtful accounts decreased by 0.5% year-over-year, from $427.00M to $425.00M.
- What is the long-term trend for Pfizer's allowance for doubtful accounts?
- Over 5 years (2020 to 2025), Pfizer's allowance for doubtful accounts has grown at a -3.4% compound annual growth rate (CAGR), from $508.00M to $427.00M.
- What does allowance for doubtful accounts mean?
- The estimated amount of customer debt that the company expects will not be paid.